IRIDEX Corporation (IRIX)
USD 1.19
(0.85%)
USD 1.19
(0.85%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 2.74 Million USD | 55.23% |
| 2022 | 1.76 Million USD | -33.4% |
| 2021 | 2.65 Million USD | -36.58% |
| 2020 | 4.18 Million USD | 30.51% |
| 2019 | 3.2 Million USD | 0.0% |
| 2018 | - USD | 0.0% |
| 2017 | - USD | 0.0% |
| 2016 | - USD | 0.0% |
| 2015 | - USD | 0.0% |
| 2014 | - USD | 0.0% |
| 2013 | - USD | 0.0% |
| 2012 | - USD | 0.0% |
| 2011 | - USD | 0.0% |
| 2010 | - USD | -100.0% |
| 2009 | 3.52 Million USD | -41.33% |
| 2008 | 6 Million USD | -39.27% |
| 2007 | 9.87 Million USD | 0.0% |
| 2006 | - USD | 0.0% |
| 2005 | - USD | 0.0% |
| 2004 | - USD | 0.0% |
| 2003 | - USD | 0.0% |
| 2002 | - USD | 0.0% |
| 2001 | - USD | 0.0% |
| 2000 | - USD | 0.0% |
| 1999 | - USD | 0.0% |
| 1998 | - USD | 0.0% |
| 1997 | - USD | -100.0% |
| 1996 | 10 Thousand USD | 0.0% |
| 1995 | - USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 2.52 Million USD | -8.19% |
| 2024 Q2 | 2.28 Million USD | -9.2% |
| 2023 Q4 | 2.74 Million USD | 175.98% |
| 2023 Q2 | 1.25 Million USD | -17.06% |
| 2023 Q1 | 1.51 Million USD | -14.19% |
| 2023 Q3 | 995 Thousand USD | -20.97% |
| 2023 FY | 2.74 Million USD | 55.23% |
| 2022 FY | 1.76 Million USD | -33.4% |
| 2022 Q1 | 2.41 Million USD | -9.0% |
| 2022 Q2 | 2.21 Million USD | -8.32% |
| 2022 Q3 | 1.97 Million USD | -10.97% |
| 2022 Q4 | 1.76 Million USD | -10.34% |
| 2021 Q1 | 3.93 Million USD | -5.99% |
| 2021 Q4 | 2.65 Million USD | -8.16% |
| 2021 FY | 2.65 Million USD | -36.58% |
| 2021 Q3 | 2.89 Million USD | -3.28% |
| 2021 Q2 | 2.99 Million USD | -24.05% |
| 2020 Q3 | 4.5 Million USD | -10.18% |
| 2020 FY | 4.18 Million USD | 30.51% |
| 2020 Q1 | 2.86 Million USD | -10.69% |
| 2020 Q2 | 5.01 Million USD | 74.81% |
| 2020 Q4 | 4.18 Million USD | -6.93% |
| 2019 Q2 | 3.87 Million USD | -7.69% |
| 2019 FY | 3.2 Million USD | 0.0% |
| 2019 Q4 | 3.2 Million USD | -9.32% |
| 2019 Q3 | 3.53 Million USD | -8.77% |
| 2019 Q1 | 4.2 Million USD | 0.0% |
| 2018 Q3 | - USD | 0.0% |
| 2018 Q4 | - USD | 0.0% |
| 2018 Q2 | - USD | 0.0% |
| 2018 FY | - USD | 0.0% |
| 2018 Q1 | - USD | 0.0% |
| 2017 Q1 | - USD | 0.0% |
| 2017 Q3 | - USD | 0.0% |
| 2017 Q4 | - USD | 0.0% |
| 2017 FY | - USD | 0.0% |
| 2017 Q2 | - USD | 0.0% |
| 2016 Q3 | - USD | 0.0% |
| 2016 Q2 | - USD | 0.0% |
| 2016 Q1 | - USD | 0.0% |
| 2016 FY | - USD | 0.0% |
| 2016 Q4 | - USD | 0.0% |
| 2015 Q4 | - USD | 0.0% |
| 2015 Q2 | - USD | 0.0% |
| 2015 Q3 | - USD | 0.0% |
| 2015 FY | - USD | 0.0% |
| 2015 Q1 | - USD | 0.0% |
| 2014 Q1 | - USD | 0.0% |
| 2014 Q2 | - USD | 0.0% |
| 2014 FY | - USD | 0.0% |
| 2014 Q3 | - USD | 0.0% |
| 2014 Q4 | - USD | 0.0% |
| 2013 Q3 | - USD | 0.0% |
| 2013 Q1 | - USD | 0.0% |
| 2013 Q2 | - USD | 0.0% |
| 2013 FY | - USD | 0.0% |
| 2013 Q4 | - USD | 0.0% |
| 2012 FY | - USD | 0.0% |
| 2012 Q4 | - USD | 0.0% |
| 2012 Q3 | - USD | 0.0% |
| 2012 Q2 | - USD | 0.0% |
| 2012 Q1 | - USD | 0.0% |
| 2011 FY | - USD | 0.0% |
| 2011 Q1 | - USD | 0.0% |
| 2011 Q4 | - USD | 0.0% |
| 2011 Q3 | - USD | 0.0% |
| 2011 Q2 | - USD | 0.0% |
| 2010 Q4 | - USD | 0.0% |
| 2010 Q2 | - USD | 0.0% |
| 2010 Q1 | - USD | -100.0% |
| 2010 Q3 | - USD | 0.0% |
| 2010 FY | - USD | -100.0% |
| 2009 Q4 | 3.52 Million USD | 0.57% |
| 2009 Q2 | 4.47 Million USD | -18.24% |
| 2009 FY | 3.52 Million USD | -41.33% |
| 2009 Q1 | 5.47 Million USD | -8.72% |
| 2009 Q3 | 3.5 Million USD | -21.84% |
| 2008 Q4 | 6 Million USD | 0.0% |
| 2008 Q2 | 6 Million USD | 13.61% |
| 2008 FY | 6 Million USD | -39.27% |
| 2008 Q1 | 5.28 Million USD | -46.54% |
| 2008 Q3 | 6 Million USD | 0.0% |
| 2007 Q3 | 10.42 Million USD | 11.2% |
| 2007 Q4 | 9.87 Million USD | -5.2% |
| 2007 FY | 9.87 Million USD | 0.0% |
| 2007 Q1 | 11.13 Million USD | 0.0% |
| 2007 Q2 | 9.37 Million USD | -15.86% |
| 2006 Q4 | - USD | 0.0% |
| 2006 FY | - USD | 0.0% |
| 2006 Q1 | - USD | 0.0% |
| 2006 Q2 | - USD | 0.0% |
| 2006 Q3 | - USD | 0.0% |
| 2005 FY | - USD | 0.0% |
| 2005 Q3 | - USD | 0.0% |
| 2005 Q4 | - USD | 0.0% |
| 2005 Q1 | - USD | 0.0% |
| 2005 Q2 | - USD | 0.0% |
| 2004 Q3 | - USD | 0.0% |
| 2004 Q4 | - USD | 0.0% |
| 2004 Q2 | - USD | 0.0% |
| 2004 Q1 | - USD | 0.0% |
| 2004 FY | - USD | 0.0% |
| 2003 Q3 | - USD | 0.0% |
| 2003 Q4 | - USD | 0.0% |
| 2003 Q2 | - USD | 0.0% |
| 2003 FY | - USD | 0.0% |
| 2003 Q1 | - USD | 0.0% |
| 2002 FY | - USD | 0.0% |
| 2002 Q1 | - USD | 0.0% |
| 2002 Q2 | - USD | 0.0% |
| 2002 Q3 | - USD | 0.0% |
| 2002 Q4 | - USD | 0.0% |
| 2001 Q2 | - USD | 0.0% |
| 2001 Q3 | - USD | 0.0% |
| 2001 Q4 | - USD | 0.0% |
| 2001 FY | - USD | 0.0% |
| 2001 Q1 | - USD | 0.0% |
| 2000 Q4 | - USD | 0.0% |
| 2000 Q1 | - USD | 0.0% |
| 2000 Q2 | - USD | 0.0% |
| 2000 Q3 | - USD | 0.0% |
| 2000 FY | - USD | 0.0% |
| 1999 Q1 | - USD | 0.0% |
| 1999 FY | - USD | 0.0% |
| 1999 Q2 | - USD | 0.0% |
| 1999 Q3 | - USD | 0.0% |
| 1999 Q4 | - USD | 0.0% |
| 1998 Q3 | - USD | 0.0% |
| 1998 FY | - USD | 0.0% |
| 1998 Q1 | - USD | 0.0% |
| 1998 Q2 | - USD | 0.0% |
| 1998 Q4 | - USD | 0.0% |
| 1997 FY | - USD | -100.0% |
| 1997 Q1 | 10 Thousand USD | 0.0% |
| 1997 Q2 | 10 Thousand USD | 0.0% |
| 1997 Q3 | 10 Thousand USD | 0.0% |
| 1997 Q4 | - USD | -100.0% |
| 1996 Q3 | 10 Thousand USD | 0.0% |
| 1996 Q4 | 10 Thousand USD | 0.0% |
| 1996 FY | 10 Thousand USD | 0.0% |
| 1996 Q2 | - USD | 0.0% |
| 1995 Q4 | - USD | 0.0% |
| 1995 FY | - USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| electroCore, Inc. | 626 Thousand USD | -338.658% |
| NeuroPace, Inc. | 72.39 Million USD | 96.207% |
| Sight Sciences, Inc. | 35.41 Million USD | 92.246% |
| TriSalus Life Sciences, Inc. | 1.59 Million USD | -72.163% |
| SI-BONE, Inc. | 38.99 Million USD | 92.958% |
| Anika Therapeutics, Inc. | 29.03 Million USD | 90.543% |
| Accelerate Diagnostics, Inc. | 39.22 Million USD | 92.998% |
| Cerus Corporation | 95.99 Million USD | 97.14% |
| Axonics, Inc. | 27.61 Million USD | 90.057% |
| 908 Devices Inc. | 5.94 Million USD | 53.81% |
| Treace Medical Concepts, Inc. | 70.3 Million USD | 96.094% |
| TELA Bio, Inc. | 42.78 Million USD | 93.581% |
| Venus Concept Inc. | 79.69 Million USD | 96.554% |
| Tivic Health Systems, Inc. | 369 Thousand USD | -644.173% |
| RxSight, Inc. | 3.01 Million USD | 8.831% |
| LENSAR, Inc. | 2.3 Million USD | -18.926% |
| Rapid Micro Biosystems, Inc. | 7.34 Million USD | 62.619% |
| LivaNova PLC | 640.4 Million USD | 99.571% |
| Inspira Technologies Oxy B.H.N. Ltd. | 2.34 Million USD | -16.951% |
| Lucid Diagnostics Inc. | 15.25 Million USD | 81.999% |
| Alphatec Holdings, Inc. | 541.67 Million USD | 99.493% |
| Apyx Medical Corporation | 38.5 Million USD | 92.868% |
| Cutera, Inc. | 431.91 Million USD | 99.364% |
| STRATA Skin Sciences, Inc. | 15.63 Million USD | 82.435% |
| BioSig Technologies, Inc. | 452 Thousand USD | -507.522% |
| Integra LifeSciences Holdings Corporation | 1.68 Billion USD | 99.837% |
| Bioventus Inc. | 409.47 Million USD | 99.329% |
| Envoy Medical, Inc. | 404 Thousand USD | -579.703% |
| Helius Medical Technologies, Inc. | 57 Thousand USD | -4717.544% |
| Outset Medical, Inc. | 136.18 Million USD | 97.984% |
| Nexalin Technology, Inc. | 4463.00 USD | -61428.12% |
| PROCEPT BioRobotics Corporation | 79.2 Million USD | 96.533% |
| IRadimed Corporation | 2.04 Million USD | -34.407% |
| PAVmed Inc | 48.72 Million USD | 94.364% |
| INVO Bioscience, Inc. | 8.68 Million USD | 68.377% |
| Movano Inc. | 252 Thousand USD | -989.683% |
| Cytek Biosciences, Inc. | 33.17 Million USD | 91.722% |
| NeuroOne Medical Technologies Corporation | 184.4 Thousand USD | -1389.154% |
| Spectral AI, Inc. | 1.28 Million USD | -113.033% |
| Viemed Healthcare, Inc. | 10.27 Million USD | 73.265% |
| Varex Imaging Corporation | 469.5 Million USD | 99.415% |
| Quipt Home Medical Corp. | 98.94 Million USD | 97.225% |
| IceCure Medical Ltd | 599 Thousand USD | -358.431% |
| Pulmonx Corporation | 41.42 Million USD | 93.371% |
| Modular Medical, Inc. | 1.19 Million USD | -130.756% |
| ReShape Lifesciences Inc. | 262 Thousand USD | -948.092% |
| Insulet Corporation | 1.44 Billion USD | 99.81% |
| Semler Scientific, Inc. | 70 Thousand USD | -3822.857% |
| ClearPoint Neuro, Inc. | 13.94 Million USD | 80.303% |
| Orthofix Medical Inc. | 134.19 Million USD | 97.954% |
| InMode Ltd. | 9.01 Million USD | 69.546% |
| Bruker Corporation | 1.37 Billion USD | 99.801% |
| Surmodics, Inc. | 29.4 Million USD | 90.661% |
| Cytosorbents Corporation | 18.31 Million USD | 85.005% |
| iCAD, Inc. | 461 Thousand USD | -495.662% |
| DexCom, Inc. | 2.59 Billion USD | 99.894% |
| Align Technology, Inc. | 96.96 Million USD | 97.168% |
| ZimVie Inc. | 521.92 Million USD | 99.474% |
| Nexalin Technology, Inc. | 4463.00 USD | -61428.12% |
| DIH Holdings US, Inc. Class A Common Stock | 1.99 Million USD | -37.541% |
| BrainsWay Ltd. | 471 Thousand USD | -483.015% |
| Tandem Diabetes Care, Inc. | 415.66 Million USD | 99.339% |
| Profound Medical Corp. | 7.9 Million USD | 65.242% |
| enVVeno Medical Corporation | 1.4 Million USD | -95.863% |
| Nuwellis, Inc. | 981 Thousand USD | -179.918% |
| Nano-X Imaging Ltd. | 8.39 Million USD | 67.294% |
| Aethlon Medical, Inc. | 940.31 Thousand USD | -192.029% |
| Inogen, Inc. | 21.92 Million USD | 87.474% |
| MaxCyte, Inc. | 18.74 Million USD | 85.349% |
| iRhythm Technologies, Inc. | 129.82 Million USD | 97.885% |
| OrthoPediatrics Corp. | 23.76 Million USD | 88.443% |
| DIH Holding US, Inc. Warrants | 1.99 Million USD | -37.541% |
| InspireMD, Inc. | 1.59 Million USD | -72.163% |
| PAVmed Inc. | 48.72 Million USD | 94.364% |
| Monogram Orthopaedics, Inc. | 491.99 Thousand USD | -458.14% |
| BIOLASE, Inc. | 17.91 Million USD | 84.668% |
| Beyond Air, Inc. | 17.83 Million USD | 84.605% |
| FONAR Corporation | 41.67 Million USD | 93.411% |
| AxoGen, Inc. | 69.29 Million USD | 96.037% |
| Vivani Medical, Inc. | 20.69 Million USD | 86.732% |
| Tactile Systems Technology, Inc. | 50.37 Million USD | 94.549% |
| Inari Medical, Inc. | 32.04 Million USD | 91.431% |
| UFP Technologies, Inc. | 46.03 Million USD | 94.035% |
| QT Imaging Holdings, Inc. | 3.07 Million USD | 10.585% |
| Heart Test Laboratories, Inc. | 1.03 Million USD | -164.971% |
| Co-Diagnostics, Inc. | 2.99 Million USD | 8.178% |
| Tenon Medical, Inc. | 1.17 Million USD | -134.101% |
| Autonomix Medical, Inc. Common Stock | 1 Million USD | -174.052% |
| CVRx, Inc. | 30.61 Million USD | 91.03% |
| AdaptHealth Corp. | 2.29 Billion USD | 99.88% |
| Sintx Technologies, Inc. | 4.24 Million USD | 35.312% |
| Vivos Therapeutics, Inc. | 1.99 Million USD | -37.644% |
| NanoVibronix, Inc. | 5000.00 USD | -54820.0% |
| Quanterix Corporation | 41.46 Million USD | 93.377% |
| Inspira Technologies Oxy B.H.N. Ltd. | 2.34 Million USD | -16.951% |
| Sensus Healthcare, Inc. | 783 Thousand USD | -250.702% |
| Pacific Biosciences of California, Inc. | 933.93 Million USD | 99.706% |
| TransMedics Group, Inc. | 515.94 Million USD | 99.468% |
| ReWalk Robotics Ltd. | 1.9 Million USD | -44.298% |
| NeuroMetrix, Inc. | 240.87 Thousand USD | -1040.006% |
| Hyperfine, Inc. | 185 Thousand USD | -1384.324% |
| Establishment Labs Holdings Inc. | 192.22 Million USD | 98.571% |
| Biomerica, Inc. | 785 Thousand USD | -249.809% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 449.48 Thousand USD | -510.924% |
| Bluejay Diagnostics, Inc. | 370.1 Thousand USD | -641.952% |
| Silk Road Medical, Inc | 84.63 Million USD | 96.755% |